Molecular pathways of nonalcoholic fatty liver disease development and progression
F Bessone, MV Razori, MG Roma - Cellular and Molecular Life Sciences, 2019 - Springer
Nonalcoholic fatty liver disease (NAFLD) is a main hepatic manifestation of metabolic
syndrome. It represents a wide spectrum of histopathological abnormalities ranging from …
syndrome. It represents a wide spectrum of histopathological abnormalities ranging from …
The Nrf2 pathway in liver diseases
J Zhou, Q Zheng, Z Chen - Frontiers in Cell and Developmental …, 2022 - frontiersin.org
Oxidative stress is the leading cause of most liver diseases, such as drug-induced liver
injury, viral hepatitis, and alcoholic hepatitis caused by drugs, viruses, and ethanol. The …
injury, viral hepatitis, and alcoholic hepatitis caused by drugs, viruses, and ethanol. The …
[HTML][HTML] Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
Peroxisome proliferator-activated receptor α (PPARα) is a ligand-activated transcription
factor belonging, together with PPARγ and PPARβ/δ, to the NR1C nuclear receptor …
factor belonging, together with PPARγ and PPARβ/δ, to the NR1C nuclear receptor …
Targeting oxidative stress for the treatment of liver fibrosis
T Luangmonkong, S Suriguga, HAM Mutsaers… - Reviews of Physiology …, 2018 - Springer
Oxidative stress is a reflection of the imbalance between the production of reactive oxygen
species (ROS) and the scavenging capacity of the antioxidant system. Excessive ROS …
species (ROS) and the scavenging capacity of the antioxidant system. Excessive ROS …
Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation
W Peverill, LW Powell, R Skoien - International journal of molecular …, 2014 - mdpi.com
Non-alcoholic steatohepatitis (NASH) is characterised by hepatic steatosis and inflammation
and, in some patients, progressive fibrosis leading to cirrhosis. An understanding of the …
and, in some patients, progressive fibrosis leading to cirrhosis. An understanding of the …
Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver
SL Friedman - Physiological reviews, 2008 - journals.physiology.org
The hepatic stellate cell has surprised and engaged physiologists, pathologists, and
hepatologists for over 130 years, yet clear evidence of its role in hepatic injury and fibrosis …
hepatologists for over 130 years, yet clear evidence of its role in hepatic injury and fibrosis …
Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury
SL Friedman - Journal of Biological Chemistry, 2000 - ASBMB
Encapsulation of injury with fibrosis is a highly evolved response of adult tissues. In liver, the
components of the process have been greatly clarified, leading to a coherent view of how …
components of the process have been greatly clarified, leading to a coherent view of how …
Glucagon‐like peptide‐1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high‐fat diet in nonalcoholic …
G Svegliati‐Baroni, S Saccomanno… - Liver …, 2011 - Wiley Online Library
Abstract Background/Aims: High‐fat dietary intake and low physical activity lead to insulin
resistance, nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis …
resistance, nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis …
Pathogenesis of liver fibrosis: role of oxidative stress
G Poli - Molecular aspects of medicine, 2000 - Elsevier
In the liver, the progressive accumulation of connective tissue, a complex and dynamic
process termed fibrosis, represents a very frequent event following a repeated or chronic …
process termed fibrosis, represents a very frequent event following a repeated or chronic …
Stiffening hydrogels for investigating the dynamics of hepatic stellate cell mechanotransduction during myofibroblast activation
SR Caliari, M Perepelyuk, BD Cosgrove, SJ Tsai… - Scientific reports, 2016 - nature.com
Tissue fibrosis contributes to nearly half of all deaths in the developed world and is
characterized by progressive matrix stiffening. Despite this, nearly all in vitro disease models …
characterized by progressive matrix stiffening. Despite this, nearly all in vitro disease models …